Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer

Mark T. Fleming, Guru Sonpavde, Michael Kolodziej, Sanjay Awasthi, Thomas E. Hutson, Danko Martincic, Ashutosh Rastogi, Steven R. Rousey, Ralph E. Weinstein, Matthew D. Galsky, William R. Berry, Yunfei Wang, Kristi A. Boehm, Lina Asmar, Mary A. Rauch, Tomasz M. Beer

    Research output: Contribution to journalArticle

    27 Scopus citations

    Fingerprint Dive into the research topics of 'Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences